Definitive Healthcare Stock Jumps 13% on Advent International Buyout Offer

Key Facts

In a move reflecting continued private equity appetite for the healthcare technology sector, mid-cap stocks have seen significant price action. According to reports, Definitive Healthcare shares surged 13% following a definitive buyout proposal from Advent International. This jump is primarily driven by investor optimism regarding the potential acquisition premium offered for the healthcare data provider.

This M&A activity highlights the growing interest in specialized health-tech firms by major investment entities like Advent International. Based on analyst facts, the offer places the company at the center of trader attention, though the finalization of the deal remains subject to board and regulatory approvals, keeping the stock under close watch to assess the likelihood of completion.

As of September 2, 2026, current price levels remain sensitive to further developments in the negotiation process. Looking ahead, investors are monitoring broader catalysts including the U.S. Goods Trade Balance and Initial Jobless Claims, which may influence overall market sentiment and capital flows into private equity transactions in the coming days.